National Vaccine
Information Center

Your Health. Your Family. Your Choice.

MedAlerts Home
Search Results

From the 7/23/2021 release of VAERS data:

This is VAERS ID 1340329

Case Details

VAERS ID: 1340329 (history)  
Form: Version 2.0  
Age: 17.0  
Sex: Male  
Location: Texas  
   Days after vaccination:24
Submitted: 0000-00-00
Entered: 2021-05-22
Vaccin­ation / Manu­facturer Lot / Dose Site / Route

Administered by: Pharmacy       Purchased by: ?
Symptoms: Chest pain, SARS-CoV-2 test, Troponin, Troponin increased
SMQs:, Myocardial infarction (narrow), Gastrointestinal nonspecific symptoms and therapeutic procedures (broad), Cardiomyopathy (broad), COVID-19 (broad)

Life Threatening? No
Birth Defect? No
Died? No
Permanent Disability? No
Recovered? Yes
Office Visit? Yes
ER Visit? No
ER or Doctor Visit? Yes
Hospitalized? Yes, 4 days
   Extended hospital stay? No
Previous Vaccinations:
Other Medications:
Current Illness:
Preexisting Conditions: Medical History/Concurrent Conditions: Hospitalization (Vaccine received during existing hospitalization)
Diagnostic Lab Data: Test Date: 20210502; Test Name: Covid covid test type post vaccination= Nasal Swab; Test Result: Negative ; Test Date: 20210502; Test Name: Elevated troponin; Result Unstructured Data: Test Result:Elevated
CDC Split Type: USPFIZER INC2021508963

Write-up: Acute chest pain; Elevated troponin 16; This is spontaneous report received from a contactable Healthcare professional. A 17-year-old male patient received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE) intramuscularly on 08Apr2021 13:15 (Batch/Lot Number: EW0151) (at 17-year-old) as first dose, single in arm left for COVID-19 immunisation. Other unspecified Pfizer vaccine was received via an unspecified route of administration on 08Apr2021 (Batch/Lot Number: EW0170) as second dose, single in arm. Medical history included ongoing hospitalization (Vaccine received during existing hospitalization). The patient''s other concomitant medications were not reported. No other vaccines within 4 weeks prior to the COVID vaccine. Other medications received within 2 weeks of vaccination was reported as unknown. On 02May2021 04:00 AM, the patient experienced acute chest pain and elevated troponin 16, he was admitted to hospital. It''s reported AE resulted in: Doctor or other healthcare professional office/clinic visit, Emergency room/department or urgent care, Hospitalization, Prolongation of existing hospitalization (vaccine received during existing hospitalization). Prior to vaccination, the patient was not diagnosed with COVID-19. On 02May2021, PCR Nasal Swab was performed and showed negative. Ketorolac tromethamine (TORADOL) and ibuprofen (MOTRIN) were received as treatment. Duration of hospitalization was 4 (discharged on 06May2021). The outcome of the event was resolved in May2021.; Sender''s Comments: Based on the strong temporal relation, the association between chest pan, troponin increased and vaccine administration cannot be completely ruled out with the information available. The impact of this report on the benefit/risk profile of the Pfizer product is evaluated as part of Pfizer procedures for safety evaluation, including the review and analysis of aggregate data for adverse events. Any safety concern identified as part of this review, as well as any appropriate action in response, will be promptly notified to regulatory authorities, Ethics Committees, and Investigators, as appropriate.

New Search

Link To This Search Result:

Copyright © 2021 National Vaccine Information Center. All rights reserved.
21525 Ridgetop Circle, Suite 100, Sterling, VA 20166